Stanton Marshall S., SVP of Clinical and Medical Affairs at Artivion Inc. ($AORT), sold about $5.7 million in company shares through 22 open market transactions over the past year. His most recent sale occurred on March 3, 2026. These sales rank him 1,756th among 11,678 insiders in our database by total value sold, below the average of $8.6 million per insider and 6 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 2149 | $37.78 | 60,097.0000 | 49,330,000 | 3.45% | 0.00% |
| March 2, 2026 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 21838 | $0.00 | 62,246.0000 | 49,330,000 | 54.04% | 0.04% |
| March 2, 2026 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1513 | $38.02 | 40,408.0000 | 49,330,000 | 3.61% | 0.00% |
| Feb. 24, 2026 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1259 | $35.69 | 41,921.0000 | 49,330,000 | 2.92% | 0.00% |
| Feb. 23, 2026 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 2423 | $37.59 | 43,180.0000 | 49,330,000 | 5.31% | 0.00% |
| Dec. 31, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 316 | $26.14 | 45,603.0000 | 48,862,000 | 0.70% | 0.00% |
| June 30, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 534 | $24.30 | 45,287.0000 | 43,432,000 | 1.19% | 0.00% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Stock Options (Right to buy) | 1355 | $0.00 | 27,075.0000 | 48,862,000 | 4.77% | 0.00% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 14586 | $44.92 | 50,468.0000 | 48,862,000 | 22.42% | 0.03% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 8370 | $45.35 | 44,753.0000 | 48,862,000 | 15.76% | 0.02% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 18705 | $44.91 | 53,123.0000 | 48,862,000 | 26.04% | 0.04% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Common Stock | 27075 | $11.03 | 71,828.0000 | 48,862,000 | 60.50% | 0.06% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 5715 | $45.35 | 44,753.0000 | 48,862,000 | 11.32% | 0.01% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 11888 | $44.14 | 44,753.0000 | 48,862,000 | 20.99% | 0.02% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Common Stock | 2033 | $18.44 | 46,786.0000 | 48,862,000 | 4.54% | 0.00% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 2033 | $44.32 | 44,753.0000 | 48,862,000 | 4.35% | 0.00% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Common Stock | 1355 | $11.03 | 46,108.0000 | 48,862,000 | 3.03% | 0.00% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1355 | $44.28 | 44,753.0000 | 48,862,000 | 2.94% | 0.00% |
| Nov. 20, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Stock Options (Right to buy) | 2033 | $0.00 | 20,301.0000 | 48,862,000 | 9.10% | 0.00% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Common Stock | 20301 | $18.44 | 65,054.0000 | 48,862,000 | 45.36% | 0.04% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Stock Options (Right to buy) | 27075 | $0.00 | 0.0000 | 48,862,000 | 100.00% | 0.06% |
| Nov. 21, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Stock Options (Right to buy) | 20301 | $0.00 | 0.0000 | 48,862,000 | 100.00% | 0.04% |
| Nov. 13, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 4993 | $45.86 | 56,641.0000 | 48,862,000 | 8.10% | 0.01% |
| Nov. 10, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 2566 | $44.62 | 61,634.0000 | 48,862,000 | 4.00% | 0.01% |
| Aug. 27, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Common Stock | 18200 | $11.03 | 82,400.0000 | 48,592,000 | 28.35% | 0.04% |
| Aug. 27, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | M | Stock Option (Right to Buy) | 18200 | $0.00 | 0.0000 | 48,592,000 | 100.00% | 0.04% |
| Aug. 27, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 18200 | $44.02 | 64,200.0000 | 48,592,000 | 22.09% | 0.04% |
| June 17, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 13764 | $29.50 | 65,436.0000 | 43,432,000 | 17.38% | 0.03% |
| June 17, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1236 | $29.50 | 64,200.0000 | 43,432,000 | 1.89% | 0.00% |
| June 13, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 8747 | $28.46 | 96,585.0000 | 43,432,000 | 8.30% | 0.02% |
| June 13, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1253 | $28.47 | 95,332.0000 | 43,432,000 | 1.30% | 0.00% |
| June 13, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 14306 | $28.42 | 81,026.0000 | 43,432,000 | 15.01% | 0.03% |
| June 13, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1826 | $28.43 | 79,200.0000 | 43,432,000 | 2.25% | 0.00% |
| May 9, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 4811 | $29.13 | 105,332.0000 | 43,432,000 | 4.37% | 0.01% |
| May 9, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 5737 | $29.13 | 110,143.0000 | 43,432,000 | 4.95% | 0.01% |
| March 6, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 19240 | $0.00 | 117,483.0000 | 43,432,000 | 19.58% | 0.04% |
| March 6, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1603 | $24.80 | 115,880.0000 | 43,432,000 | 1.36% | 0.00% |
| Feb. 28, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 18398 | $0.00 | 98,243.0000 | 43,432,000 | 23.04% | 0.04% |
| Feb. 24, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 2299 | $27.31 | 82,233.0000 | 43,432,000 | 2.72% | 0.01% |
| Feb. 24, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1246 | $27.31 | 79,845.0000 | 43,432,000 | 1.54% | 0.00% |
| Feb. 24, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 672 | $27.31 | 81,091.0000 | 43,432,000 | 0.82% | 0.00% |
| Feb. 24, 2025 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 470 | $27.31 | 81,763.0000 | 43,432,000 | 0.57% | 0.00% |
| Dec. 31, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 381 | $21.63 | 84,532.0000 | 43,392,000 | 0.45% | 0.00% |
| June 30, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 855 | $15.20 | 84,151.0000 | 42,569,000 | 1.03% | 0.00% |
| March 20, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 2183 | $20.39 | 83,296.0000 | 42,569,000 | 2.55% | 0.01% |
| March 1, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1506 | $18.72 | 85,479.0000 | 42,569,000 | 1.73% | 0.00% |
| Feb. 26, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1431 | $20.27 | 81,726.0000 | 42,569,000 | 1.72% | 0.00% |
| Feb. 27, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 465 | $19.83 | 81,261.0000 | 42,569,000 | 0.57% | 0.00% |
| March 1, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 5724 | $0.00 | 86,985.0000 | 42,569,000 | 7.04% | 0.01% |
| Feb. 23, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 5386 | $0.00 | 74,089.0000 | 42,569,000 | 7.84% | 0.01% |
| Feb. 26, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1576 | $20.27 | 72,513.0000 | 42,569,000 | 2.13% | 0.00% |
| Feb. 23, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 10644 | $0.00 | 83,157.0000 | 42,569,000 | 14.68% | 0.03% |
| March 5, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1506 | $18.72 | 85,438.0000 | 42,569,000 | 1.73% | 0.00% |
| March 1, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 5724 | $0.00 | 86,944.0000 | 42,569,000 | 7.05% | 0.01% |
| Feb. 27, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 465 | $19.83 | 81,220.0000 | 42,569,000 | 0.57% | 0.00% |
| Feb. 26, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1448 | $20.27 | 81,685.0000 | 42,569,000 | 1.74% | 0.00% |
| Feb. 23, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 5386 | $0.00 | 74,089.0000 | 42,569,000 | 7.84% | 0.01% |
| Feb. 26, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | S | Common Stock | 1600 | $20.27 | 72,489.0000 | 42,569,000 | 2.16% | 0.00% |
| Feb. 23, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 10644 | $0.00 | 83,133.0000 | 42,569,000 | 14.68% | 0.03% |
| Feb. 23, 2024 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 14800 | $0.00 | 68,703.0000 | 42,569,000 | 27.46% | 0.03% |
| June 30, 2023 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 1261 | $10.30 | 53,338.0000 | 41,830,000 | 2.42% | 0.00% |
| Dec. 31, 2023 | ARTIVION, INC. | $AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | A | Common Stock | 565 | $14.61 | 53,903.0000 | 41,830,000 | 1.06% | 0.00% |